{"id":"lipo-pge1","safety":{"commonSideEffects":[{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Gastrointestinal discomfort"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PGE1 is a naturally occurring prostaglandin that binds to EP receptors on vascular tissue, triggering relaxation of smooth muscle and increasing cAMP levels, which leads to vasodilation and improved microcirculation. The lipid formulation enhances stability and bioavailability. This mechanism helps restore blood flow to ischemic tissues and reduce platelet aggregation.","oneSentence":"Lipo-PGE1 is a lipid-formulated prostaglandin E1 that promotes vasodilation and improves blood flow by activating prostanoid receptors on vascular smooth muscle and endothelial cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:52:31.765Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Peripheral arterial occlusive disease"},{"name":"Diabetic angiopathy"},{"name":"Ischemic ulcers"}]},"trialDetails":[{"nctId":"NCT07121634","phase":"NA","title":"Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Raid M. Al-Ani","startDate":"2024-01-01","conditions":"Cervical Ripening","enrollment":80},{"nctId":"NCT05379556","phase":"","title":"LOng COvid COmorbidities: Andrological, Reproductive, Sexual Dysfunctions in Patients Recovered From COVID-19","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT06044883","phase":"PHASE1, PHASE2","title":"Radiological Evaluation of the Penis Before and After a Botox Injection","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-01","conditions":"Erectile Dysfunction","enrollment":32},{"nctId":"NCT04536363","phase":"PHASE2","title":"Cri Analog PG1 Effectiveness and Safety in Covid-19","status":"WITHDRAWN","sponsor":"Alonso Vera Torres","startDate":"2020-12-03","conditions":"Covid19","enrollment":""},{"nctId":"NCT04955847","phase":"","title":"Efficacy and Safety of Oral Misoprostol 25 μg vs. Vaginal Dinoprostone in Induction of Labor at Term","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2021-07-05","conditions":"Induction of Labor, Vaginal Delivery, Cesarean Section","enrollment":700},{"nctId":"NCT02895373","phase":"PHASE2","title":"PGE1 as Additive Anticoagulant in ECMO-Therapy","status":"TERMINATED","sponsor":"Thomas Staudinger","startDate":"2016-07","conditions":"Respiratory Distress Syndrome, Adult, Extracorporeal Membrane Oxygenation","enrollment":50},{"nctId":"NCT03615846","phase":"","title":"Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan","status":"UNKNOWN","sponsor":"Accriva Diagnostics","startDate":"2021-02-15","conditions":"Platelet Aggregation, Coronary Artery Disease","enrollment":147},{"nctId":"NCT02314728","phase":"NA","title":"Cervical Ripening in Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2014-10-01","conditions":"Pregnancy, Premature Rupture of Membranes, Preterm Premature Rupture of Membranes","enrollment":230},{"nctId":"NCT02338440","phase":"PHASE2, PHASE3","title":"Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2015-01","conditions":"Veno-occlusive Disease, Child","enrollment":30},{"nctId":"NCT04611464","phase":"","title":"Misoprostol for Spinal Stenosis","status":"COMPLETED","sponsor":"Dallas VA Medical Center","startDate":"2019-07-11","conditions":"Lumbar Spinal Stenosis, Low Back Pain","enrollment":23},{"nctId":"NCT04143685","phase":"NA","title":"Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes","status":"UNKNOWN","sponsor":"sammour.rami","startDate":"2019-12-01","conditions":"Prelabor Rupture of Membranes, Premature Rupture of Membrane","enrollment":200},{"nctId":"NCT01467076","phase":"PHASE2","title":"Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)","status":"TERMINATED","sponsor":"NICHD Neonatal Research Network","startDate":"2011-11","conditions":"Prematurity, Respiratory Insufficiency, Pulmonary Hypertension","enrollment":7},{"nctId":"NCT00598429","phase":"PHASE2","title":"Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure","status":"WITHDRAWN","sponsor":"NICHD Neonatal Research Network","startDate":"2008-05","conditions":"Infant, Newborn, Respiratory Insufficiency, Pulmonary Hypertension","enrollment":""},{"nctId":"NCT03862547","phase":"NA","title":"NGF, TrKA,p75NTR in Men With ED and Diabetes With or Without MS","status":"UNKNOWN","sponsor":"University Of Perugia","startDate":"2019-01-30","conditions":"Erectile Dysfunction","enrollment":40},{"nctId":"NCT03851562","phase":"PHASE2","title":"Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy","status":"UNKNOWN","sponsor":"Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia","startDate":"2018-06-13","conditions":"Ischemic Optic Neuropathy","enrollment":24},{"nctId":"NCT03603418","phase":"PHASE4","title":"Role Of Dexamethasone In Induction Of Labor","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2018-07-13","conditions":"Dexamethasone Effect on Induction of Labor","enrollment":80},{"nctId":"NCT00544076","phase":"PHASE3","title":"ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer","status":"TERMINATED","sponsor":"City of Hope Medical Center","startDate":"2006-01","conditions":"Prostate Cancer, Male Erectile Disorder, Stage I Prostate Cancer","enrollment":110},{"nctId":"NCT03733860","phase":"NA","title":"Cavernous Tissue Preservation During Penile Prosthesis Implantation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-11-01","conditions":"Erectile Dysfunction","enrollment":100},{"nctId":"NCT03489798","phase":"NA","title":"Comparison of Two Protocols of Misoprostol (PGE1) and the Rate of Cesarean Section Due to Failed Induction.","status":"COMPLETED","sponsor":"Saint Thomas Hospital, Panama","startDate":"2018-04-05","conditions":"Induction of Labor","enrollment":310},{"nctId":"NCT03159559","phase":"PHASE4","title":"PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2017-01","conditions":"Coronary Microvascular Perfusion in Patients With Ischemic Heart Disease","enrollment":60},{"nctId":"NCT01422226","phase":"NA","title":"Intra Uterine Device Insertion in Nulliparous Women","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2011-07","conditions":"Contraception","enrollment":3},{"nctId":"NCT02628106","phase":"PHASE4","title":"Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2015-12","conditions":"Diabetic Nephropathy","enrollment":21},{"nctId":"NCT02738177","phase":"PHASE2","title":"Misoprostol Versus Effox as Cervical Ripening Agent Prior Surgical Evacuation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-11","conditions":"Cervical Ripening","enrollment":90},{"nctId":"NCT02223949","phase":"PHASE2, PHASE3","title":"Labor Induction and Maternal BMI, Comparison of Different Pre-induction Cervical Ripening Methods","status":"UNKNOWN","sponsor":"Hillel Yaffe Medical Center","startDate":"2014-10","conditions":"Obesity, Labor Complications","enrollment":624},{"nctId":"NCT01840813","phase":"PHASE1","title":"Intraumbilical Misoprostol in Retained Placenta","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2011-04","conditions":"Retained Placenta","enrollment":46},{"nctId":"NCT01722513","phase":"PHASE4","title":"Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy","status":"UNKNOWN","sponsor":"Shanghai 10th People's Hospital","startDate":"2012-11","conditions":"Kidney Diseases, Diabetes Mellitus, Acute Kidney Injury","enrollment":150},{"nctId":"NCT00080808","phase":"PHASE2","title":"Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2001-08","conditions":"Prostate Cancer","enrollment":111},{"nctId":"NCT00308711","phase":"PHASE3","title":"Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2006-04","conditions":"Cervical Ripening, Labor, Induced","enrollment":1308},{"nctId":"NCT00577876","phase":"NA","title":"Assessment of the Functional Significance of Accessory Pudendal Arteries","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-09","conditions":"Prostate Cancer","enrollment":38},{"nctId":"NCT01245855","phase":"PHASE3","title":"Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2011-01","conditions":"Prostaglandin E1, Percutaneous Coronary Intervention","enrollment":100},{"nctId":"NCT00314548","phase":"NA","title":"Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2006-05","conditions":"Adult Respiratory Distress Syndrome, Pulmonary Hypertension","enrollment":67},{"nctId":"NCT00324948","phase":"PHASE2","title":"Topical Alprostadil for Female Sexual Arousal Disorder","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2004-09","conditions":"Sexual Dysfunction, Physiological","enrollment":300},{"nctId":"NCT00053716","phase":"PHASE2","title":"Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease","status":"UNKNOWN","sponsor":"Endovasc","startDate":"2003-02","conditions":"Peripheral Vascular Disease","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":112,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["alprostadil","aspirin","clopidogrel","antidiabetic drugs","Prostaglandin E1 incorporated in lipid microspheres"],"phase":"marketed","status":"active","brandName":"Lipo-PGE1","genericName":"Lipo-PGE1","companyName":"West China Hospital","companyId":"west-china-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lipo-PGE1 is a small molecule intervention used in clinical trials for conditions such as veno-occlusive disease, retained placenta, and respiratory insufficiency in infants and newborns. It is being studied as a potential treatment in a pharmacokinetic study for preventing veno-occlusive disease after hematopoietic stem cell transplantation.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1981-10-16T00:00:00.000Z","mah":"PFIZER","brand_name_local":"PROSTIN VR PEDIATRIC","application_number":"NDA018484"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1996-11-19T00:00:00.000Z","mah":"VIATRIS","brand_name_local":"MUSE","application_number":"NDA020700"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1997-06-12T00:00:00.000Z","mah":"ENDO OPERATIONS","brand_name_local":"EDEX","application_number":"NDA020649"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1999-04-30T00:00:00.000Z","mah":"MEITHEAL","brand_name_local":"ALPROSTADIL","application_number":"ANDA075196"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2002-06-11T00:00:00.000Z","mah":"PFIZER","brand_name_local":"CAVERJECT IMPULSE","application_number":"NDA021212"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}